CVS Health Corporation

NYSE: CVS · Real-Time Price · USD
68.41
1.68 (2.52%)
At close: Aug 15, 2025, 10:14 AM

CVS Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
386.64B 378.96B 372.81B 368.91B 363.25B 360.94B 357.78B 347.81B 339.2B 330.92B 322.47B 315.23B 307.86B 299.84B 292.11B 285.06B 278.32B 271.05B
Cost of Revenue
333.19B 325.72B 321.41B 316.53B 309.85B 307.32B 303.35B 293.44B 285.02B 276.48B 268.01B 260.93B 254.26B 246.9B 240.06B 234.71B 228.95B 221.52B
Gross Profit
53.45B 53.24B 51.4B 52.38B 53.4B 53.62B 54.43B 54.37B 54.18B 54.44B 54.46B 54.3B 53.6B 52.94B 52.05B 50.35B 49.37B 49.52B
Operating Income
8.96B 9.62B 8.52B 9.52B 12.38B 12.57B 13.74B 13.99B 6.38B 7.81B 7.91B 6.52B 13.5B 13.16B 13.19B 13.49B 13.68B 14.03B
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
6.5B 7.18B 6.15B 6.73B 9.64B 9.87B 11.17B 11.58B 4.11B 5.67B 5.79B 4.26B 10.85B 10.45B 10.42B 10.07B 9.74B 9.96B
Net Income
4.53B 5.28B 4.61B 5.02B 7.19B 7.32B 8.34B 8.6B 2.93B 4.06B 4.28B 3.28B 8.29B 8.04B 7.91B 7.58B 7.2B 7.39B
Selling & General & Admin
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
44.49B 43.62B 42.88B 42.86B 41.02B 41.05B 40.69B 40.38B 47.8B 46.62B 46.54B 47.77B 40.1B 39.78B 38.85B 36.87B 35.7B 35.49B
Operating Expenses
44.49B 43.62B 42.88B 42.86B 41.02B 41.05B 40.69B 40.38B 47.8B 46.62B 46.54B 47.77B 40.1B 39.78B 38.85B 36.87B 35.7B 35.49B
Interest Expense
3.06B 3.03B 2.96B 2.89B 2.83B 2.79B 2.66B 2.52B 2.39B 2.29B 2.29B 2.34B 2.38B 2.43B 2.5B 2.57B 2.7B 2.83B
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
377.69B 369.34B 364.29B 359.39B 350.87B 348.37B 344.03B 333.82B 332.82B 323.11B 314.55B 308.7B 294.36B 286.68B 278.92B 271.57B 264.65B 257.02B
Income Tax Expense
2.01B 1.94B 1.56B 1.72B 2.44B 2.52B 2.81B 2.96B 1.16B 1.59B 1.5B 965M 2.57B 2.42B 2.52B 2.49B 2.52B 2.55B
Shares Outstanding (Basic)
1.27B 1.26B 1.26B 1.26B 1.26B 1.26B 1.29B 1.29B 1.28B 1.28B 1.31B 1.31B 1.31B 1.31B 1.32B 1.32B 1.32B 1.31B
Shares Outstanding (Diluted)
1.27B 1.26B 1.26B 1.26B 1.26B 1.27B 1.29B 1.29B 1.29B 1.29B 1.32B 1.31B 1.32B 1.33B 1.34B 1.33B 1.33B 1.32B
EPS (Basic)
3.60 4.20 3.67 3.95 5.64 5.71 6.49 6.68 2.33 3.16 3.29 2.50 6.30 6.10 6.00 5.75 5.47 5.63
EPS (Diluted)
3.58 4.19 3.66 3.95 5.63 5.70 6.47 6.65 2.31 3.12 3.24 2.45 6.24 6.05 5.96 5.72 5.45 5.61
EBITDA
13.01B 14.82B 13.7B 14.2B 17.02B 17.16B 18.2B 18.38B 10.71B 12.14B 12.31B 10.89B 17.6B 17.32B 17.43B 17.18B 16.95B 17.27B
EBIT
9.55B 10.21B 9.1B 9.62B 12.47B 12.66B 13.83B 14.1B 6.51B 7.96B 8.08B 6.6B 13.22B 12.88B 12.92B 12.65B 12.44B 12.79B
Depreciation & Amortization
3.46B 4.61B 4.6B 4.58B 4.55B 4.5B 4.37B 4.28B 4.2B 4.18B 4.23B 4.3B 4.38B 4.43B 4.51B 4.54B 4.52B 4.48B